BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
FABP1
,
T cell receptor signaling pathway
,
Leukemia
,
Prostate
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protein kinase inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Developing irreversible inhibitors of the protein kinase cysteinome.
PfRIO-2 kinase is a potential therapeutic target of antimalarial protein kinase inhibitors.
HPLC-DAD protein kinase inhibitor analysis in human serum.
Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP.
Improved synthesis of a DNA-dependent protein kinase inhibitor IC86621.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Hepatotoxicity Related to Protein Kinase Inhibitors
The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multi…
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Hu…
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors)
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Pro…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ